Stay updated on Selinexor Combo for High-Risk Myeloma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Combo for High-Risk Myeloma Clinical Trial page.

Latest updates to the Selinexor Combo for High-Risk Myeloma Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.5.4 has been added to the study record history, representing an updated version of the record. The previous revision v3.5.3 is no longer listed in the version history, indicating that changes were incorporated in the new revision.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedVersion label on the Record History updated from v3.5.2 to v3.5.3. This reflects a maintenance update to the page's underlying system or formatting, not a modification to study content.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision entry v3.5.2 was added to the history and the previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed from the history.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded revision v3.4.3 to the Record History and removed revision v3.4.2.SummaryDifference0.1%

- Check99 days agoChange DetectedA new Revision: v3.4.2 was added to the history. The page also removes the government funding lapse notice and the older Revision: v3.4.1 entry.SummaryDifference0.7%

Stay in the know with updates to Selinexor Combo for High-Risk Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Combo for High-Risk Myeloma Clinical Trial page.